Yaz Lawsuit Filed on Behalf of Young Woman Who Allegedly Suffered Deep Vein Thrombosis and other Serious Yaz Side Effects

Share Article

Yaz and Yasmin Lawsuits Pending in a Federal Multidistrict Litigation in U.S. District Court, Southern District of Illinois are Now Being Settled. Gilman Law LLP Urges all Victims of Possible Yaz and Yasmin Side Effects, Including Blood Clots, Deep Vein Thrombosis, Pulmonary Embolism, Heart Attack, Stroke or Gallbladder Disease, to Seek Legal Counsel Immediately to Ensure Their Opportunity to Recover Compensation for Their Injuries is Not Lost.

Gilman Law LLP | A Leading National Law Firm

Gilman Law LLP | A Leading National Law Firm

hundreds of reports of injury and death have been submitted to the FDA in association with Yaz and Yasmin

Gilman Law LLP announces that they have filed a Yaz lawsuit on behalf of a young woman from Wisconsin who allegedly suffered serious Yaz side effects, including a life-threatening type of blood clot called deep vein thrombosis, due to her use of the popular birth control pill. The Yaz lawsuit was filed on May 24, 2012, in U.S. District Court, Southern District of Illinois, where nearly 10,000 Yaz and Yasmin lawsuits have been consolidated in a multidistrict litigation (MDL 2100). All of the Yaz and Yasmin lawsuits filed in the litigation allege the oral contraceptives caused serious side effects, including blood clots, deep vein thrombosis, pulmonary embolism, heart attack, stroke and gall bladder disease. (Case No. 3:12-cv-10862-DRH-PMF)

According to the lawsuit, the Plaintiff sustained serious Yaz side effects, including but not limited to a deep vein thrombosis, in September 2011. Her injuries resulted in amputation of her right leg, ongoing emotional distress, mental anguish, pain and suffering, medical, health, incidental and related expenses, medical monitoring and/or medications, and the fear of developing additional health consequences. The complaint alleges that the Plaintiff’s injuries were caused by the wrongful acts, omissions, and fraudulent misrepresentations of Bayer and other Defendants. It further alleges that had the Defendants properly disclosed risks associated with Yaz, the Plaintiff would not have used it and would not have suffered the serious and permanent injuries described in the lawsuit.

According to the complaint, Yaz was approved by the Food and Drug Administration (FDA) in 2006, while its predecessor, Yasmin, was approved for use in 2001. Yasmin and Yaz are different from other combined hormonal birth control pills in that they contain drospirenone, a progestin that is associated with hyperkalemia, a condition that occurs when potassium levels in the body become too high. Among other things, hyperkalemia can disrupt normal heart rhythms, which can potentially slow the flow of blood to the heart to the point that blood clots form. The complaint alleges that during the brief time that Yasmin and Yaz have been sold in the U.S., hundreds of reports of injury and death have been submitted to the FDA in association with Yaz and Yasmin, including reports of cardiac arrhythmia, cardiac arrest, intracardiac thrombus, pulmonary embolism, and stroke. The FDA announced in April 2012 that it was requiring that the labels for drospirenone birth control pills be updated to warn that these contraceptives may be linked to a higher risk of blood clots. [http://www.fda.gov/Drugs/DrugSafety/ucm273021.htm

The complaint also points out that Bayer and other Defendants have been warned at least three times by the FDA - in 2003, 2008 and 2009 - for misleading the public through the use of ads which overstated the efficacy of Yaz and minimized serious risks associated with the drug. Indeed, the FDA concluded that Defendants’ over-promotion of Yaz was so severe that it required Bayer to run new TV advertisements to correct the previous misleading and deceptive ads. The lawsuit states that the Defendants ultimately agreed to spend at least $20 million on corrective TV advertisements and to submit all Yaz advertisements to the FDA for advanced screening for six years.

According to Gilman Law LLP, it was recently reported by the Madison Record that Yaz and Yasmin lawsuits pending in the Southern District of Illinois are being settled. So far, some 1,500 complaints have been resolved, and it is expected that settlements in nearly all cases will occur within the year. Gilman Law LLP is urging anyone who suffered a serious Yaz or Yasmin side effect, including blood clots, deep vein thrombosis, pulmonary embolism, heart attacks, strokes or gallbladder disease, to seek legal counsel immediately, before this litigation comes to an end. Once Yaz and Yasmin lawsuits are settled, there will be no further opportunity for recovering compensation from Bayer and other Defendants. For a free Yaz or Yasmin lawsuit consultation, please contact Gilman Law LLP by visiting Gilmanlawllp.com, or call Toll Free at 1-888-252-0048.
[http://www.madisonrecord.com/news/245130-settlements-in-yaz-litigation-continue-mediator-is-cautiously-optimistic-that-end-is-in-sight

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Kenneth G. Gilman, Esq.

Consumer Protection attorneys
Follow us on
Visit website